“White lung” is not a medical diagnosis. It’s a descriptive term for what lungs look like on an X-ray or CT scan when infection, fluid, or inflammation fills the air sacs that are normally dark on imaging. The phrase gained widespread attention in late 2023 when media reports highlighted clusters of pediatric pneumonia cases in China and parts of the United States, but health authorities confirmed those cases were caused by common, well-known respiratory pathogens.
Why Lungs Appear White on Imaging
Healthy lungs are full of air, which shows up as dark space on a chest X-ray. When something partially or fully displaces that air, the affected areas appear lighter or completely white. This can happen when the tiny air sacs in the lungs fill with mucus, pus, or fluid from an immune response, or when the walls of those air sacs become thickened from inflammation. The more air that gets displaced, the whiter the lung tissue appears.
Radiologists use the term “ground glass opacity” for a hazy, whitish appearance where you can still see the outlines of blood vessels and airways behind it. Denser white patches, called consolidation, mean the air sacs are more completely filled. Most types of pneumonia produce some degree of white patches on imaging, which is why “white lung” doesn’t point to any single disease. It’s a visual finding with a long list of possible causes, ranging from bacterial and viral infections to autoimmune conditions and fluid overload.
What Caused the 2023 Outbreaks
In November 2023, the World Health Organization flagged media reports about clusters of undiagnosed pneumonia in children’s hospitals in Beijing, Liaoning, and other parts of northern China. WHO formally requested additional data from Chinese authorities and held a teleconference with the Chinese Center for Disease Control and Prevention and Beijing Children’s Hospital. The conclusion: there was no novel pathogen involved. The cases were driven by a combination of Mycoplasma pneumoniae (a common bacterium), respiratory syncytial virus (RSV), adenovirus, influenza, and SARS-CoV-2.
Chinese health authorities reported that Mycoplasma pneumoniae cases had been rising since May, with RSV, adenovirus, and influenza adding to the burden starting in October. Some of these increases came earlier in the season than usual, but the pattern mirrored what other countries had already experienced after lifting COVID-19 restrictions. During the pandemic, reduced social contact meant fewer people were exposed to common respiratory infections. That created a larger pool of susceptible children once normal mixing resumed. No unusual clinical presentations were reported.
Around the same time, Warren County, Ohio reported 142 cases of pediatric pneumonia since August, meeting the state’s threshold for an outbreak. CDC Director Mandy Cohen characterized both the domestic and international situations as seasonal trends, noting that some years are worse than others. There was no evidence linking the Ohio cases to other states or countries, and no indication of a new pandemic-level threat.
The Main Pathogen Behind the Headlines
Mycoplasma pneumoniae was the bacterium most frequently mentioned in connection with the white lung reports. It’s one of the most common causes of pneumonia in school-age children and young adults, and it typically causes what’s often called “walking pneumonia,” a milder form where people feel sick but can usually still go about their day. In some cases, though, it produces more significant lung involvement that shows up dramatically on imaging.
What makes Mycoplasma pneumoniae unusual is that it lacks a cell wall, which means the most commonly prescribed antibiotics for other bacterial infections, like penicillin and related drugs, simply don’t work against it. Treatment relies on a different class of antibiotics, with the specific choice depending on the patient’s age. For children, one particular class of antibiotics is generally the first option. If symptoms don’t improve, doctors may switch to alternatives, though some of those carry side-effect concerns for young children and pregnant women.
Mycoplasma pneumoniae can also set the stage for additional infections. There’s evidence that infection with this bacterium can intensify subsequent infections with various respiratory viruses and other bacteria, which may partly explain why some children developed more severe illness during the 2023 surge.
Symptoms to Recognize
The symptoms associated with white lung cases are the same as those of pneumonia generally. They include a persistent dry cough, fever, sore throat, shortness of breath, chest pain, fatigue, headaches, and increased mucus production. In milder cases, these symptoms may feel like a bad cold that just won’t clear up.
More severe pneumonia triggers a stronger immune response. Your body floods the air sacs with mucus, pus, and other fluids to fight the infection, but that congestion makes it harder for oxygen to reach your blood. Signs that the infection has become serious include a noticeably fast heart rate, severe chest pain, confusion, difficulty breathing, and a bluish tint to the skin, lips, or nails. In children, look for rapid breathing, flaring nostrils, or the skin pulling inward between the ribs with each breath.
Who Is Most at Risk
Pneumonia risk follows a U-shaped curve across the lifespan. Children younger than 5 face elevated risk, with the youngest children (around age 1) at the highest risk in that group. On the other end, adults 65 and older are more vulnerable, and that risk keeps climbing with age. An 80-year-old faces a higher chance of severe pneumonia than a 65-year-old.
The 2023 white lung reports focused heavily on school-age children, which aligns with Mycoplasma pneumoniae’s typical pattern. This bacterium spreads easily in settings where children are in close contact, like schools and daycare centers. The post-pandemic “immunity gap,” where children missed years of normal exposure to circulating germs, likely amplified the size of the outbreaks.
Recovery Timeline
For mild pneumonia, some people feel better and return to normal routines within a week. More significant infections can take a month or longer for full recovery. Serious lung infections sometimes require weeks to months before you feel like yourself again, even after the infection itself has cleared. The fluid buildup and cellular debris left in the airways take time for the body to reabsorb and clear out, which is why a lingering cough and fatigue are common even after treatment.
The white appearance on imaging can also persist after symptoms improve. Radiological clearing tends to lag behind clinical recovery, so a follow-up X-ray taken while you’re feeling better might still show some haziness. This is normal and doesn’t necessarily mean the infection is still active.